RDGT logo

RIDGETECH INC

RDGTNASDAQ
πŸ† #4231 by market capUS Equity
$0.95β–Ό $0.03 (βˆ’3.01%)
Market closed Β· at close
1hβ€”
24hβ–Ό 3.0%
7dβ–² 42.0%
14dβ–² 23.1%
30dβ–Ό 35.2%
1yβ–Ό 99.5%
🏦Market Cap
$3M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-24.1%
Declining
πŸ“ŠGross Margin
-7.4%
Thin
πŸ’΅FCF Margin
14.7%
Healthy
βš–οΈP/S Ratio
0.0x
Cheap
Otter Score
64
Fair

Trading Snapshot

Day Range
$0.95 – $0.97
52-Week Range
$0.67 – $760.50
Volume
$1.60B
Avg Volume
$1.22B
Shares Outstanding
3.6M
Next Earnings
Oct 3, 2026

Fundamentals Snapshot

Annual Revenue
$132M
Last Q Revenue
$69M
P/E Ratio
0.3
P/S Ratio
0.0x
EPS (TTM)
$326.05
Dividend Yield
β€”

Why Investors Own RDGT

  • βœ“High-growth profile β€” revenue up +32.8% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 60% gross margin and 15% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$132Mβ–² +35.6% YoY
Gross Margin (TTM)
59.7%β–² +0.5% YoY
Operating Income (TTM)
$16Mβ–² +35.6% YoY
Free Cash Flow (TTM)
$19Mβ–² +35.6% YoY

About RIDGETECH INC

Ridgetech, Inc. operates as a wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. It operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. The company engages in offline and online wholesale distribution of pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products comprising consumable, seasonal, and promotional items. It also distributes other healthcare products, such as health food, cosmetics, and daily necessities. The company was formerly known as China Jo-Jo Drugstores, Inc. and changed its name to Ridgetech, Inc. in February 2024. Ridgetech, Inc. is headquartered in Hangzhou, China.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
64/100

Analyst Price Target

β“˜
Average Target
$1.23
β–² +28.6% Upside
High Target$1.37
Low Target$0.97
Based on 39 analysts

Latest News & Updates